At a Glance
OrbiMed Advisors is a venture capital firm based in New York, NY founded in 1989. The firm focuses on Series A, Series B+ investments across sectors including Biotech, Digital Health. The firm manages $15B in assets under management. Notable portfolio companies include Foundation Medicine, 10x Genomics, Veracyte, Moderna, BioNTech, Guardant Health and Exact Sciences. Healthcare-focused investment platform spanning all stages from seed through IPO in biotech, pharmaceuticals, and digital health.
“Healthcare-focused investment platform spanning all stages from seed through IPO in biotech, pharmaceuticals, and digital health.”
Carter Neild
Managing Partner, OrbiMed Advisors
David Bonita
General Partner, OrbiMed Advisors
Geoffrey C. Hsu
General Partner, OrbiMed Advisors
Matthew Rizzo
General Partner, OrbiMed Advisors
Peter Thompson
General Partner, OrbiMed Advisors
Scotland Stevens
General Partner, OrbiMed Advisors
Sven H. Borho
Managing Partner, OrbiMed Advisors
OrbiMed Advisors primarily invests at the Series A, Series B+ stages. This means they focus on companies that are scaling their go-to-market after proving product-market fit.
OrbiMed Advisors is headquartered in New York, NY. Many of their portfolio companies are also based in this region, though they invest across geographies.
OrbiMed Advisors focuses on investments in Biotech, Digital Health. Their portfolio reflects deep expertise and networks within these sectors.
OrbiMed Advisors's typical investment check size ranges from $1M to $75M. Actual amounts may vary based on the stage, sector, and specific opportunity.
OrbiMed Advisors manages approximately $15B in assets under management (AUM) across their funds.